BRIGHT MINDS BIOSCIENCES ANNOUNCES AT-THE-MARKET OFFERING

Lane

Equity financing

Announced

04 Sep 2025

Province

British Columbia

Industry

Unclassified

Status

Announced

What the filing says

Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (" Bright Minds " or the " Company ") announces that it has entered into an equity distribution agreement (the " Equity Distribution Agreement ") providing for an at-the-market equity offering program (" ATM ") with Piper Sandler & Co. and Cantor Fitzgerald & Co. (the " Agents ").

Source

BRIGHT MINDS BIOSCIENCES ANNOUNCES AT-THE-MARKET OFFERING

The terms are in the subscriber edition

This transaction carries the consideration.

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe